BACKGROUND: Prolongation of the QT interval is associated with an increased risk of atrial fibrillation (AF) and stroke. OBJECTIVES: The purpose of this analysis was to determine if AF explains the association between prolonged QT and stroke. METHODS: A total of 6305 participants (mean age 62 ± 10 years; 54% women; 38% whites; 27% blacks; 23% Hispanics; 12% Chinese-Americans) from the Multi-Ethnic Study of Atherosclerosis (MESA) were included in this analysis. A linear scale was used to compute heart rate-adjusted QT (QT(a)). Prolonged QT(a) was defined as ≥ 460 ms in women and ≥ 450 ms in men. Incident AF cases were identified using hospital discharge records and Medicare claims data. Vascular neurologists adjudicated stroke events by medical record review. Cox regression was used to examine the association between prolonged QT(a) and stroke with and without AF. RESULTS: A total of 216 (3.4%) of study participants had prolonged QT(a). Over a median follow-up of 8.5 years, 280 (4.4%) participants developed AF and 128 (2.0%) participants developed stroke. In a multivariable Cox regression analysis adjusted for socio-demographics, cardiovascular risk factors, and potential confounders, prolonged QT(a) was associated with an increased risk of AF (HR = 1.7, 95% CI 1.1, 2.6) and stroke (HR = 2.3, 95% CI 1.3, 4.1). When AF was included as a time-dependent covariate, the association between prolonged QT(a) and stroke was not substantively altered (HR = 2.4, 95% CI 1.3, 4.3). CONCLUSION: The increased risk of stroke in those with prolonged QT potentially is not explained by documented AF. Further research is needed to determine if subclinical AF explains the association between the QT interval and stroke.
BACKGROUND: Prolongation of the QT interval is associated with an increased risk of atrial fibrillation (AF) and stroke. OBJECTIVES: The purpose of this analysis was to determine if AF explains the association between prolonged QT and stroke. METHODS: A total of 6305 participants (mean age 62 ± 10 years; 54% women; 38% whites; 27% blacks; 23% Hispanics; 12% Chinese-Americans) from the Multi-Ethnic Study of Atherosclerosis (MESA) were included in this analysis. A linear scale was used to compute heart rate-adjusted QT (QT(a)). Prolonged QT(a) was defined as ≥ 460 ms in women and ≥ 450 ms in men. Incident AF cases were identified using hospital discharge records and Medicare claims data. Vascular neurologists adjudicated stroke events by medical record review. Cox regression was used to examine the association between prolonged QT(a) and stroke with and without AF. RESULTS: A total of 216 (3.4%) of study participants had prolonged QT(a). Over a median follow-up of 8.5 years, 280 (4.4%) participants developed AF and 128 (2.0%) participants developed stroke. In a multivariable Cox regression analysis adjusted for socio-demographics, cardiovascular risk factors, and potential confounders, prolonged QT(a) was associated with an increased risk of AF (HR = 1.7, 95% CI 1.1, 2.6) and stroke (HR = 2.3, 95% CI 1.3, 4.1). When AF was included as a time-dependent covariate, the association between prolonged QT(a) and stroke was not substantively altered (HR = 2.4, 95% CI 1.3, 4.3). CONCLUSION: The increased risk of stroke in those with prolonged QT potentially is not explained by documented AF. Further research is needed to determine if subclinical AF explains the association between the QT interval and stroke.
Authors: Hee-Jin Jun; S Bryn Austin; Sarah A Wylie; Heather L Corliss; Benita Jackson; Donna Spiegelman; Mathew J Pazaris; Rosalind J Wright Journal: Cancer Causes Control Date: 2010-07-18 Impact factor: 2.506
Authors: Pentti M Rautaharju; Borys Surawicz; Leonard S Gettes; James J Bailey; Rory Childers; Barbara J Deal; Anton Gorgels; E William Hancock; Mark Josephson; Paul Kligfield; Jan A Kors; Peter Macfarlane; Jay W Mason; David M Mirvis; Peter Okin; Olle Pahlm; Gerard van Herpen; Galen S Wagner; Hein Wellens Journal: J Am Coll Cardiol Date: 2009-03-17 Impact factor: 24.094
Authors: Elsayed Z Soliman; George Howard; James F Meschia; Mary Cushman; Paul Muntner; Patrick M Pullicino; Leslie A McClure; Suzanne Judd; Virginia J Howard Journal: Stroke Date: 2011-08-04 Impact factor: 7.914
Authors: Elsayed Z Soliman; George Howard; Mary Cushman; Brett Kissela; Dawn Kleindorfer; Anh Le; Suzanne Judd; Leslie A McClure; Virginia J Howard Journal: J Am Coll Cardiol Date: 2012-04-17 Impact factor: 24.094
Authors: David J Gladstone; Melanie Spring; Paul Dorian; Val Panzov; Kevin E Thorpe; Judith Hall; Haris Vaid; Martin O'Donnell; Andreas Laupacis; Robert Côté; Mukul Sharma; John A Blakely; Ashfaq Shuaib; Vladimir Hachinski; Shelagh B Coutts; Demetrios J Sahlas; Phil Teal; Samuel Yip; J David Spence; Brian Buck; Steve Verreault; Leanne K Casaubon; Andrew Penn; Daniel Selchen; Albert Jin; David Howse; Manu Mehdiratta; Karl Boyle; Richard Aviv; Moira K Kapral; Muhammad Mamdani Journal: N Engl J Med Date: 2014-06-26 Impact factor: 91.245
Authors: Mala C Mandyam; Elsayed Z Soliman; Alvaro Alonso; Thomas A Dewland; Susan R Heckbert; Eric Vittinghoff; Steven R Cummings; Patrick T Ellinor; Bernard R Chaitman; Karen Stocke; William B Applegate; Dan E Arking; Javed Butler; Laura R Loehr; Jared W Magnani; Rachel A Murphy; Suzanne Satterfield; Anne B Newman; Gregory M Marcus Journal: Heart Rhythm Date: 2013-07-18 Impact factor: 6.343
Authors: Nikhil Patel; Wesley T O'Neal; S Patrick Whalen; Elsayed Z Soliman Journal: Ann Noninvasive Electrocardiol Date: 2017-06-29 Impact factor: 1.468
Authors: Itai M Magodoro; Alfred J Albano; Rahul Muthalaly; Bruce Koplan; Crystal M North; Dagmar Vořechovská; Jordan Downey; John Kraemer; Martino Vaglio; Fabio Badilini; Bernard Kakuhire; Alexander C Tsai; Mark J Siedner Journal: Glob Heart Date: 2018-12-21
Authors: Insa E Emrich; Adam M Zawada; Jens Martens-Lobenhoffer; Danilo Fliser; Stefan Wagenpfeil; Gunnar H Heine; Stefanie M Bode-Böger Journal: Clin Res Cardiol Date: 2017-11-03 Impact factor: 5.460
Authors: Hanumantha R Jogu; Wesley T O'Neal; Stephen T Broughton; Amit J Shah; Zhu-Ming Zhang; Elsayed Z Soliman Journal: Ann Noninvasive Electrocardiol Date: 2016-08-12 Impact factor: 1.468
Authors: Parag Ravindra Gajendragadkar; Adam Von Ende; Maysson Ibrahim; Elsa Valdes-Marquez; Christian Fielder Camm; Federico Murgia; Alexander Stiby; Barbara Casadei; Jemma C Hopewell Journal: PLoS Med Date: 2021-05-13 Impact factor: 11.069
Authors: Katherine C Wu; Fiona Bhondoekhan; Sabina A Haberlen; Hiroshi Ashikaga; Todd T Brown; Matthew J Budoff; Gypsyamber D'Souza; Jared W Magnani; Lawrence A Kingsley; Frank J Palella; Joseph B Margolick; Otoniel Martínez-Maza; Sean F Altekruse; Elsayed Z Soliman; Wendy S Post Journal: Ann Noninvasive Electrocardiol Date: 2019-09-19 Impact factor: 1.468
Authors: Jonathan Yap; Ai Zhen Jin; Shwe Zin Nyunt; Tze Pin Ng; A Mark Richards; Carolyn S P Lam Journal: PLoS One Date: 2016-05-05 Impact factor: 3.240